NO975360D0 - Peptid som inhiberer forhöyede triglyceridnivåer i blod og midler som inneholder nevnte peptid som aktiv komponent - Google Patents

Peptid som inhiberer forhöyede triglyceridnivåer i blod og midler som inneholder nevnte peptid som aktiv komponent

Info

Publication number
NO975360D0
NO975360D0 NO975360A NO975360A NO975360D0 NO 975360 D0 NO975360 D0 NO 975360D0 NO 975360 A NO975360 A NO 975360A NO 975360 A NO975360 A NO 975360A NO 975360 D0 NO975360 D0 NO 975360D0
Authority
NO
Norway
Prior art keywords
peptide
triglyceride levels
active component
blood
well
Prior art date
Application number
NO975360A
Other languages
English (en)
Other versions
NO325836B1 (no
NO975360L (no
Inventor
Kyoichi Kagawa
Hisako Matsutaka
Chizuko Fukuhama
Hiroaki Fujino
Masahiro Numata
Kazuzhisa Honda
Toyoo Nakamura
Original Assignee
Hankyu Kyoei Bussan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hankyu Kyoei Bussan Co Ltd filed Critical Hankyu Kyoei Bussan Co Ltd
Publication of NO975360D0 publication Critical patent/NO975360D0/no
Publication of NO975360L publication Critical patent/NO975360L/no
Publication of NO325836B1 publication Critical patent/NO325836B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19975360A 1996-03-22 1997-11-21 Peptid som inhiberer forhoyede triglyseridnivaer i blod, samt anvendelse derav NO325836B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8066916A JP2805194B2 (ja) 1996-03-22 1996-03-22 血中トリグリセリド濃度上昇抑制ペプチド及び当該ペプチドを有効成分として含む血中トリグリセリド濃度上昇抑制剤
PCT/JP1996/001570 WO1997035875A1 (fr) 1996-03-22 1996-06-10 Peptide destine a inhiber l'elevation du taux de triglycerides dans le sang et agent d'inhibition contenant ce peptide en tant qu'ingredient actif

Publications (3)

Publication Number Publication Date
NO975360D0 true NO975360D0 (no) 1997-11-21
NO975360L NO975360L (no) 1998-01-21
NO325836B1 NO325836B1 (no) 2008-07-28

Family

ID=13329785

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975360A NO325836B1 (no) 1996-03-22 1997-11-21 Peptid som inhiberer forhoyede triglyseridnivaer i blod, samt anvendelse derav

Country Status (11)

Country Link
US (1) US5958885A (no)
EP (1) EP0838473B1 (no)
JP (1) JP2805194B2 (no)
KR (1) KR100264344B1 (no)
AT (1) ATE225803T1 (no)
AU (1) AU690853B2 (no)
CA (1) CA2221767C (no)
DK (1) DK0838473T3 (no)
ES (1) ES2184865T3 (no)
NO (1) NO325836B1 (no)
WO (1) WO1997035875A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000095794A (ja) * 1998-09-22 2000-04-04 Itoham Foods Inc エンケファリン分解酵素の阻害剤
JP2000264845A (ja) * 1999-02-04 2000-09-26 Nippon Synthetic Chem Ind Co Ltd:The コレステロール降下剤及びその用途
US7060467B2 (en) 2000-03-13 2006-06-13 Monsanto Technology Llc Recombinant proteins containing repeating units
DE10105041A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
US20070254889A1 (en) * 2001-04-23 2007-11-01 Lee-Way Jin Compounds and methods useful for rescuing cells from beta-amyloid toxicity and treatment of Alzheimer's disease
US20040018959A1 (en) * 2002-05-02 2004-01-29 Randall S. Hickle System and methods of lipid removal from the body
GB0211849D0 (en) * 2002-05-23 2002-07-03 Mok Kenneth H Improvments to retro-inverso isomers
NO322425B1 (no) * 2003-07-04 2006-10-02 Berge Biomed As Anvendelse av et hydrolysat av proteinholdig fiskemateriale for fremstilling av et farmasoytisk middel for behandling og/eller hindring av patologisk hoye nivaer av tracylglyceroler, hyperkolesterolemia, hyperhomocysteinemia, eller patologisk lave nivaer av beta-oksidasjon i et dyr eller menneske.
US20080063781A1 (en) * 2004-09-30 2008-03-13 Suntory Limited Globin Digest Containing, Yeast-Fermented Beverages
CA2585442A1 (en) * 2004-11-15 2006-05-18 Mg Pharma Inc. Protein hydrolysate with antidiabetic effect
JP4395658B2 (ja) 2005-11-17 2010-01-13 エムジーファーマ株式会社 コレステロール再上昇抑制用組成物およびその用法
JP5175484B2 (ja) * 2007-03-30 2013-04-03 名古屋製酪株式会社 血中中性脂肪濃度上昇抑制剤
US8394769B2 (en) * 2007-08-07 2013-03-12 Mg Pharma Inc. Anti-hypertensive agent
WO2018001273A1 (zh) * 2016-06-30 2018-01-04 江西本草天工科技有限责任公司 肽或其盐、其制备方法、及其制备预防和/或治疗肝损伤药物的用途
CN107551258B (zh) * 2016-06-30 2021-01-05 江西本草天工科技有限责任公司 用于预防和/或治疗肝损伤的vvyp
CN107556363B (zh) * 2016-06-30 2021-03-30 江西本草天工科技有限责任公司 肽或其盐及其制备方法
JP2024102740A (ja) * 2023-01-19 2024-07-31 ロート製薬株式会社 疲労軽減又は疲労回復促進用組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723443A (en) * 1988-02-02 1998-03-03 Hankyu-Kyoei Bussan Co. Ltd. Lipid metabolism promoting agent and its use
CA1335567C (en) * 1988-02-02 1995-05-16 Kyoichi Kagawa Lipid metabolism promoting agent
JP2764276B2 (ja) * 1988-09-06 1998-06-11 仙味エキス株式会社 機能性新規ペプチド及びその利用
JPH0331298A (ja) * 1989-06-28 1991-02-12 Ajinomoto Co Inc プロリルエンドペプチターゼ阻害ペプチド
JPH03120224A (ja) * 1989-10-04 1991-05-22 Ajinomoto Co Inc 新規ペプチドおよびこれを含有する降圧剤
JP3312944B2 (ja) * 1993-03-24 2002-08-12 伊藤ハム株式会社 脂肪細胞分化抑制ペプチド及び当該ペプチドを有効成分とする脂肪細胞分化抑制剤
JP2800877B2 (ja) * 1993-12-28 1998-09-21 伊藤ハム株式会社 血中トリグリセリド濃度上昇抑制ペプチド及び当該ペプチドを有効成分として含む血中トリグリセリド濃度上昇抑制剤

Also Published As

Publication number Publication date
AU5912096A (en) 1997-10-17
JP2805194B2 (ja) 1998-09-30
NO325836B1 (no) 2008-07-28
EP0838473A4 (en) 2000-04-05
ATE225803T1 (de) 2002-10-15
DK0838473T3 (da) 2003-02-17
NO975360L (no) 1998-01-21
CA2221767C (en) 2001-01-23
AU690853B2 (en) 1998-04-30
JPH09255698A (ja) 1997-09-30
US5958885A (en) 1999-09-28
KR100264344B1 (ko) 2000-08-16
CA2221767A1 (en) 1997-10-02
EP0838473B1 (en) 2002-10-09
ES2184865T3 (es) 2003-04-16
EP0838473A1 (en) 1998-04-29
KR19990021880A (ko) 1999-03-25
WO1997035875A1 (fr) 1997-10-02

Similar Documents

Publication Publication Date Title
NO975360L (no) Peptid som inhiberer forhöyede triglyseridnivåer i blod og midler som inneholder nevnte peptid som aktiv komponent
ES2153415T3 (es) Peptido inhibidor de la diferenciacion de adipocitos e inhibidor de la diferenciacion de adipocitos que contiene dicho peptido como ingrediente activo.
DE60305055D1 (de) Verwendung von ghrelin zur behandlung von unterernährung von gastrektomiepatienten
PT1011723E (pt) Factor de crescimento tumorigenico de 88 kda e antagonistas
ATE477812T1 (de) Verwendung von tryptophanreichen peptiden aus molkenproteinhydrolysate zur behandlung von übergewicht und fettleibigkeit
Croom et al. Neuropeptide Y, peptide YY and aluminum in Alzheimer’s disease:: Is there an etiological relationship?
DE69735883D1 (de) Methode zur behandlung von muskelkrankheiten
ATE183651T1 (de) Verwendung von wachstumsfaktor igf-ii zur beahandlung von gastrointestinalen störungen
ATE165008T1 (de) Methode zur behandlung intestinaler krankheiten
NO995692D0 (no) Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse
DE69723982D1 (de) Behandlung des partiellen wachstumshormon-unempfindlichkeitssyndroms
DK0838474T3 (da) Peptid som inhiberer blodtriglyceridstigning og blodtriglyceridstigningsinhibitor indeholdende nævnte peptid som aktiv ingrediens
ATE108063T1 (de) Heilmittel zur behandlung von toxoplasmose.
Jansson et al. Acquired flexural deformity of the distalinterphalangeal joint in horses: Treatment by desmotomy of the accessory ligament of the deep digital flexor tendon: A retrospective study
Mishra et al. Lameness
Shivaprakash et al. Incidence and management of congenital malformations of muscular system and limbs
CN107509987A (zh) 一种具有生物活性无鳞囊罗非鱼皮的制作方法
ATE218869T1 (de) Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen
CA2225412A1 (en) A peptide inhibiting elevations of triglyceride levels in blood and an agent for inhibiting elevations of triglyceride levels in blood comprising the peptide as an active component
RU97120642A (ru) Способ лечения заболеваний и повреждений плюсневых костей при тотальном дефекте
RU2002130733A (ru) Лекарственное средство для терапии кожи человека и животных

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees